查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830839

2025年全球神经再生疗法市场报告

Neuroregeneration Therapy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，神经再生疗法市场发展迅速，预计将从2024年的99.8亿美元成长到2025年的112.9亿美元，复合年增长率达13.1%。这段历史性成长时期可归因于神经系统疾病盛行率的上升、全球老年人口的成长、研发投入的增加、政府支持和资金的增加以及学术界和产业界合作的加强。

预计未来几年神经再生疗法市场将快速成长，到2029年市场规模将达到182.3亿美元，复合年增长率（CAGR）为12.7%。预测期内的成长可归因于以下因素：对神经再生疗法的需求不断增长、细胞疗法的普及、医疗保健需求的增加、生物技术投资的扩大以及人口老化的持续加剧。这段时期的主要趋势包括：干细胞治疗方法的进步、个人化医疗的发展、神经退化性疾病基因编辑技术的创新、奈米技术在药物传递中的应用以及製药公司和生物技术公司之间日益密切的合作。

神经再生疗法是一种旨在修復、再生或替换大脑、脊髓和周围神经中受损的神经细胞和组织的医疗方法，最终目标是恢復因损伤、疾病或退化性疾病而丧失的神经功能。

神经再生疗法的主要类型包括干细胞疗法、基因疗法、药物疗法和神经刺激疗法。干细胞疗法利用干细胞修復、替换或再生体内受损或病变的细胞、组织或器官。这些治疗方法采用多种技术，包括组织工程、颅脑和脊髓刺激、基于奈米技术的治疗方法递送以及生物材料开发，并且可以透过多种途径给药，包括口服、注射或植入。神经再生疗法适用于多种适应症，包括脊髓损伤、创伤性脑损伤、中风、巴金森氏症、多发性硬化症、阿兹海默症和周边神经损伤。这些治疗方法的主要最终用户包括医院、临床研究实验室、学术机构以及製药和生物技术公司。

美国在2025年春季突然提高关税及其引发的贸易摩擦对製药公司造成了严重衝击。利润丰厚的学名药生产商尤其脆弱，一些公司不得不缩减低收益药物的生产规模。生物技术公司也因关税导致的专用试剂短缺而面临临床试验延期。为因应这一局面，製药业正在印度和欧洲扩大原料药的生产，增加库存，并游说政府对基本药物给予贸易豁免。

本研究报告是商业研究公司（The Business Research Company）最新系列报告的一部分，提供神经再生疗法市场统计数据，包括全球市场规模、区域份额、竞争对手及其市场份额、详细的市场细分、市场趋势以及行业商机，为您在神经再生疗法行业取得成功提供所需数据。本神经再生疗法市场研究报告全面观点了该行业的现状和未来发展趋势，为您提供所需的一切资讯。

预计未来几年，神经系统疾病盛行率的不断上升将推动神经再生疗法市场的扩张。神经系统疾病会影响大脑、脊髓和周边神经，损害正常的神经系统功能。长期接触重金属、杀虫剂和工业化学物质会损害神经系统，增加神经退化性疾病的风险。神经再生疗法透过修復或替换受损的神经细胞和组织，恢復丧失的功能，促进大脑、脊髓和神经的癒合，进而改善运动技能、感觉和生活品质。例如，总部位于英国的世界神经病学联合会（World Federation of Neurology，一个由各国神经病学会组成的联盟）于2023年10月报告称，目前全球超过40%的人口患有神经系统疾病，预计到2050年，这一负担将几乎翻一番。因此，神经系统疾病盛行率的不断上升正在推动神经再生疗法市场的成长。

不断扩大的老龄人口预计也将推动神经再生疗法市场的成长。人口老化是指人口结构的变化，导致社会老年人口比例不断增加，进而带来社会和医疗保健方面的挑战。这一增长主要得益于医疗保健的进步和生活水准的提高，从而延长了预期寿命。神经再生疗法在治疗与年龄相关的神经系统疾病方面发挥关键作用，它透过修復受损的神经细胞、增强大脑功能和运动技能以及延缓认知衰退来提高整体生活品质。例如，英国议会研究机构－下议院图书馆在2024年7月发布的报告显示，到2022年， 老龄化岁及以上人口将占英国总人口的19%，约1270万人。预计到2072年，这一数字将增至2,210万人，占总人口的27%。因此，不断增长的老龄人口正在推动对神经再生疗法的需求。

神经再生疗法市场的公司也正在投资研发先进的解决方案，例如可吸收植入，以改善週边神经再生和患者预后。可吸收植入是医疗设备，其设计目的是在完成治疗后溶解并被人体吸收，因此无需手术取出。例如，2022年3月，美国生技公司Integra Lifesciences Holdings Corporation推出了Neuragen 3D神经引导基质，用于辅助修復週边神经断裂。该装置将Integra的牛I型胶原蛋白与一种由多孔通道组成的创新内部基质相结合，该基质可引导雪旺细胞迁移并控制轴突生长，从而创造最佳的癒合环境。这项创新代表了周边神经修復领域的一项重大进步，为外科医生提供了治疗短期至中期神经损伤的新方案，也是多年来旨在改善神经损伤患者功能恢復的研究成果。

神经再生疗法市场由提供生物材料植入服务、神经修復手术以及咨询和支持服务等服务的营业单位所获得的收益所构成。市场价值还包括服务提供者销售或包含在其服务产品中的任何相关商品的价值。神经再生疗法市场还包括生物材料、神经刺激和神经调控设备、药品以及神经电极阵列的销售。该市场的价值为“出厂价”，即商品製造商或创造者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品创造者提供的任何相关服务的价值。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球神经再生疗法：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球神经再生疗法市场：成长率分析
  • 全球神经再生疗法市场表现：规模与成长，2019-2024年
  • 全球神经再生疗法市场预测：规模与成长，2024-2029年，2034年
  • 全球神经再生疗法：潜在市场规模 (TAM)

第六章 市场细分

  • 全球神经再生疗法市场：依神经再生疗法类型、表现和预测划分，2019-2024年、2024-2029年、2034年
  • 干细胞疗法
  • 基因治疗
  • 药物治疗
  • 神经刺激疗法
  • 其他类型的神经再生疗法
  • 全球神经再生疗法市场：依技术、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 组织工程
  • 颅脊髓刺激
  • 奈米技术在药物传递的应用
  • 生物材料开发
  • 全球神经再生疗法市场依给药方式划分：绩效及预测，2019-2024年、2024-2029年、2034年
  • 口服
  • 注射
  • 嵌入式
  • 其他管理方法
  • 全球神经再生疗法市场：依适应症、疗效和预测划分，2019-2024年、2024-2029年、2034年
  • 脊髓损伤
  • 创伤性脑损伤
  • 中风
  • 帕金森氏症
  • 多发性硬化症
  • 阿兹海默症
  • 週边神经损伤
  • 其他迹象
  • 全球神经再生疗法市场按最终用户、表现和预测划分，2019-2024年、2024-2029年、2034年
  • 医院
  • 临床研究所
  • 学术机构
  • 製药和生物技术公司
  • 全球神经再生疗法市场：依干细胞疗法（按类型）细分、绩效及预测，2019-2024年、2024-2029年、2034年
  • 胚胎干细胞治疗
  • 间质干细胞疗法
  • 神经干细胞疗法
  • 诱导性多功能干细胞疗法
  • 造血干细胞疗法
  • 全球神经再生疗法市场：按基因疗法类型、表现和预测进行细分，2019-2024年、2024-2029年、2034年
  • 体内基因治疗
  • 体外基因治疗
  • 基于病毒载体的基因治疗
  • 基于非病毒载体的基因治疗
  • 基因组编辑基因疗法
  • 全球神经再生疗法市场：按治疗类型细分、表现和预测（2019-2024年、2024-2029年、2034年）
  • 神经保护药物
  • 基于神经营养因子的药物
  • 抗发炎药物
  • 抗氧化剂
  • 胆碱酯酶抑制剂
  • 全球神经再生疗法市场：按神经刺激疗法（类型）细分、表现和预测（2019-2024 年、2024-2029 年、2034 年）
  • 深部脑部刺激
  • 经颅磁刺激
  • 迷走神经刺激
  • 脊髓刺激
  • 经颅直流电刺激
  • 全球神经再生疗法市场：细分：其他类型的神经再生疗法、绩效及预测，2019-2024年、2024-2029年、2034年
  • 基于奈米技术的治疗
  • 基于外泌体的治疗方法
  • 基于生物材料的治疗方法
  • 电磁场疗法
  • 高压氧气疗法

第七章 区域和国家分析

  • 全球神经再生疗法市场：按地区、绩效和预测划分，2019-2024年、2024-2029年、2034年
  • 全球神经再生疗法市场：国家、绩效及预测，2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 神经再生疗法市场：竞争格局
  • 神经再生疗法市场：公司概况
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Novartis International AG
  • Stryker Corporation
  • Biogen Inc.
  • Synovis Life Technologies Inc.
  • Integra LifeSciences Holdings Corporation
  • AxoGen Inc.
  • Denali Therapeutics Inc.
  • Aspen Neuroscience Inc.
  • Neurona Therapeutics Inc.
  • Lineage Cell Therapeutics Inc.
  • Checkpoint Surgical Inc.
  • Stemedica Cell Technologies Inc.
  • Polyganics BV
  • Epineuron Technologies Inc.
  • NeuExcell Therapeutics Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年神经再生疗法市场：提供新机会的国家
  • 2029年神经再生疗法市场：蕴藏新机会的细分市场
  • 2029年神经再生疗法市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r37829

Neuroregeneration therapy refers to medical approaches aimed at repairing, regenerating, or replacing damaged neurons and neural tissues in the brain, spinal cord, or peripheral nerves, with the ultimate goal of restoring neurological functions lost due to injury, disease, or degenerative conditions.

The major types of neuroregeneration therapy include stem cell therapy, gene therapy, pharmacological therapy, neurostimulation therapy, and others. Stem cell therapy involves the use of stem cells to repair, replace, or regenerate damaged or diseased cells, tissues, or organs in the body. These therapies employ a range of technologies such as tissue engineering, cranial and spinal stimulation, nanotechnology-based drug delivery, and biomaterials development, and can be administered through various modes including oral, injectable, implantable, and others. Neuroregeneration therapies are applied across multiple indications, including spinal cord injury, traumatic brain injury, stroke, Parkinson's disease, multiple sclerosis, Alzheimer's disease, and peripheral nerve injury. Key end users of these therapies include hospitals, clinical research institutes, academic institutions, and pharmaceutical and biotechnology companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The neuroregeneration therapy market research report is one of a series of new reports from The Business Research Company that provides neuroregeneration therapy market statistics, including the neuroregeneration therapy industry global market size, regional shares, competitors with the neuroregeneration therapy market share, detailed neuroregeneration therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the neuroregeneration therapy industry. This neuroregeneration therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neuroregeneration therapy market size has grown rapidly in recent years. It will grow from $9.98 billion in 2024 to $11.29 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth during the historic period can be attributed to the rising prevalence of neurological disorders, the global increase in the geriatric population, expanding investments in research and development, greater government support and funding, and the growing collaborations between academia and industry.

The neuroregeneration therapy market size is expected to see rapid growth in the next few years. It will grow to $18.23 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to the increasing demand for neuroregeneration therapies, the rising adoption of cell therapies, growing healthcare needs, expanding investments in biotechnology, and the continued rise in the aging population. Key trends expected during this period include advancements in stem cell-based therapies, the development of personalized medicine, innovations in gene editing for neurodegenerative diseases, the application of nanotechnology in drug delivery, and the evolution of pharma-biotech collaborations.

The growing prevalence of neurological disorders is anticipated to drive the expansion of the neuroregeneration therapy market in the coming years. Neurological disorders affect the brain, spinal cord, or peripheral nerves, impairing normal nervous system functions. One of the key contributors to the rise in such conditions is exposure to environmental toxins, as prolonged contact with heavy metals, pesticides, and industrial chemicals can damage the nervous system and increase the risk of neurodegenerative diseases. Neuroregeneration therapy addresses these disorders by repairing or replacing damaged neurons and tissues, restoring lost functions, and promoting healing in the brain, spinal cord, and nerves to improve mobility, sensation, and quality of life. For example, in October 2023, the World Federation of Neurology, a UK-based association of national neurological societies, reported that over 40% of the global population currently suffers from a neurological condition, with this burden projected to nearly double by 2050. Consequently, the increasing prevalence of neurological disorders is fueling the growth of the neuroregeneration therapy market.

The expanding aging population is also expected to accelerate the growth of the neuroregeneration therapy market. An aging population refers to the demographic shift in which the proportion of older individuals in society rises, creating social and healthcare challenges. This growth is driven by longer life expectancy resulting from advancements in healthcare and improved living standards. Neuroregeneration therapy plays a vital role in addressing age-related neurological conditions by repairing damaged nerve cells, enhancing brain function and mobility, and slowing cognitive decline to improve overall quality of life. For instance, in July 2024, the House of Commons Library, a UK-based parliamentary research service, reported that in 2022, individuals aged 65 and over accounted for 19% of the UK's total population, around 12.7 million people. This figure is projected to rise to 22.1 million, representing 27% of the population, by 2072. As a result, the increasing elderly population is boosting demand for neuroregeneration therapies.

Companies in the neuroregeneration therapy market are also investing in advanced solutions such as resorbable implants to improve peripheral nerve regeneration and patient outcomes. Resorbable implants are medical devices designed to dissolve and be absorbed by the body after serving their purpose, thereby eliminating the need for surgical removal. For example, in March 2022, Integra LifeSciences Holdings Corporation, a US-based biotechnology company, introduced the NeuraGen 3D Nerve Guide Matrix to aid in repairing peripheral nerve discontinuities. The device combines Integra's bovine type 1 collagen with an innovative inner matrix of porous channels, creating an optimal healing environment by guiding Schwann cell migration and directing axonal growth. This innovation marked a major step forward in peripheral nerve repair, offering surgeons a new solution for short- to mid-gap nerve injuries and representing the result of years of research aimed at improving functional recovery for patients with nerve damage.

Major players in the neuroregeneration therapy market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Novartis International AG, Stryker Corporation, Biogen Inc., Synovis Life Technologies Inc., Integra LifeSciences Holdings Corporation, AxoGen Inc., Denali Therapeutics Inc., Aspen Neuroscience Inc., Neurona Therapeutics Inc., Lineage Cell Therapeutics Inc., Checkpoint Surgical Inc., Stemedica Cell Technologies Inc., Polyganics B.V., Epineuron Technologies Inc., NeuExcell Therapeutics Inc.

North America was the largest region in the neuroregeneration therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuroregeneration therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neuroregeneration therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neuroregeneration therapy market consists of revenues earned by entities by providing services such as biomaterial implantation services, surgical interventions for nerve repair, and consulting and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuroregeneration therapy market also includes sales of biomaterials, neurostimulation and neuromodulation devices, pharmaceuticals, and neural electrode arrays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuroregeneration Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuroregeneration therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuroregeneration therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neuroregeneration therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type Of Neuroregeneration Therapy: Stem Cell Therapy; Gene Therapy; Pharmacological Therapy; Neurostimulation Therapy; Other Types Of Neuroregeneration Therapy
  • 2) By Technology: Tissue Engineering; Cranial And Spinal Stimulation; Nanotechnology In Drug Delivery; Biomaterials Development
  • 3) By Mode Of Administration: Oral; Injectable; Implantable; Other Modes Of Administration
  • 4) By Indication: Spinal Cord Injury; Traumatic Brain Injury; Stroke; Parkinson's Disease; Multiple Sclerosis; Alzheimer's Disease; Peripheral Nerve Injury; Other Indications
  • 5) By End-User: Hospitals; Clinical Research Institutes; Academic Institutions; Pharmaceutical And Biotechnology Companies
  • Subsegment:
  • 1) By Stem Cell Therapy: Embryonic Stem Cell Therapy; Mesenchymal Stem Cell Therapy; Neural Stem Cell Therapy; Induced Pluripotent Stem Cell Therapy; Hematopoietic Stem Cell Therapy
  • 2) By Gene Therapy: In Vivo Gene Therapy; Ex Vivo Gene Therapy; Viral Vector Based Gene Therapy; Non Viral Vector Based Gene Therapy; Genome Editing Gene Therapy
  • 3) By Pharmacological Therapy: Neuroprotective Drugs; Neurotrophic Factor Based Drugs; Anti Inflammatory Drugs; Antioxidant Drugs; Cholinesterase Inhibitors
  • 4) By Neurostimulation Therapy: Deep Brain Stimulation; Transcranial Magnetic Stimulation; Vagus Nerve Stimulation; Spinal Cord Stimulation; Transcranial Direct Current Stimulation
  • 5) By Other Types Of Neuroregeneration Therapy: Nanotechnology Based Therapy; Exosome Based Therapy; Biomaterial Based Therapy; Electromagnetic Field Therapy; Hyperbaric Oxygen Therapy
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Sanofi S.A.; AstraZeneca PLC; Novartis International AG; Stryker Corporation; Biogen Inc.; Synovis Life Technologies Inc.; Integra LifeSciences Holdings Corporation; AxoGen Inc.; Denali Therapeutics Inc.; Aspen Neuroscience Inc.; Neurona Therapeutics Inc.; Lineage Cell Therapeutics Inc.; Checkpoint Surgical Inc.; Stemedica Cell Technologies Inc.; Polyganics B.V.; Epineuron Technologies Inc.; NeuExcell Therapeutics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neuroregeneration Therapy Market Characteristics

3. Neuroregeneration Therapy Market Trends And Strategies

4. Neuroregeneration Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neuroregeneration Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Neuroregeneration Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Neuroregeneration Therapy Market Growth Rate Analysis
  • 5.4. Global Neuroregeneration Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Neuroregeneration Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Neuroregeneration Therapy Total Addressable Market (TAM)

6. Neuroregeneration Therapy Market Segmentation

  • 6.1. Global Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stem Cell Therapy
  • Gene Therapy
  • Pharmacological Therapy
  • Neurostimulation Therapy
  • Other Types Of Neuroregeneration Therapy
  • 6.2. Global Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue Engineering
  • Cranial And Spinal Stimulation
  • Nanotechnology In Drug Delivery
  • Biomaterials Development
  • 6.3. Global Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Injectable
  • Implantable
  • Other Modes Of Administration
  • 6.4. Global Neuroregeneration Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinal Cord Injury
  • Traumatic Brain Injury
  • Stroke
  • Parkinson's Disease
  • Multiple Sclerosis
  • Alzheimer's Disease
  • Peripheral Nerve Injury
  • Other Indications
  • 6.5. Global Neuroregeneration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinical Research Institutes
  • Academic Institutions
  • Pharmaceutical And Biotechnology Companies
  • 6.6. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Embryonic Stem Cell Therapy
  • Mesenchymal Stem Cell Therapy
  • Neural Stem Cell Therapy
  • Induced Pluripotent Stem Cell Therapy
  • Hematopoietic Stem Cell Therapy
  • 6.7. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In Vivo Gene Therapy
  • Ex Vivo Gene Therapy
  • Viral Vector Based Gene Therapy
  • Non-Viral Vector Based Gene Therapy
  • Genome Editing Gene Therapy
  • 6.8. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Pharmacological Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neuroprotective Drugs
  • Neurotrophic Factor Based Drugs
  • Anti Inflammatory Drugs
  • Antioxidant Drugs
  • Cholinesterase Inhibitors
  • 6.9. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Neurostimulation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deep Brain Stimulation
  • Transcranial Magnetic Stimulation
  • Vagus Nerve Stimulation
  • Spinal Cord Stimulation
  • Transcranial Direct Current Stimulation
  • 6.10. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Other Types Of Neuroregeneration Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nanotechnology Based Therapy
  • Exosome Based Therapy
  • Biomaterial Based Therapy
  • Electromagnetic Field Therapy
  • Hyperbaric Oxygen Therapy

7. Neuroregeneration Therapy Market Regional And Country Analysis

  • 7.1. Global Neuroregeneration Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Neuroregeneration Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neuroregeneration Therapy Market

  • 8.1. Asia-Pacific Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neuroregeneration Therapy Market

  • 9.1. China Neuroregeneration Therapy Market Overview
  • 9.2. China Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neuroregeneration Therapy Market

  • 10.1. India Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neuroregeneration Therapy Market

  • 11.1. Japan Neuroregeneration Therapy Market Overview
  • 11.2. Japan Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neuroregeneration Therapy Market

  • 12.1. Australia Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neuroregeneration Therapy Market

  • 13.1. Indonesia Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neuroregeneration Therapy Market

  • 14.1. South Korea Neuroregeneration Therapy Market Overview
  • 14.2. South Korea Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neuroregeneration Therapy Market

  • 15.1. Western Europe Neuroregeneration Therapy Market Overview
  • 15.2. Western Europe Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neuroregeneration Therapy Market

  • 16.1. UK Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neuroregeneration Therapy Market

  • 17.1. Germany Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neuroregeneration Therapy Market

  • 18.1. France Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neuroregeneration Therapy Market

  • 19.1. Italy Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neuroregeneration Therapy Market

  • 20.1. Spain Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neuroregeneration Therapy Market

  • 21.1. Eastern Europe Neuroregeneration Therapy Market Overview
  • 21.2. Eastern Europe Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neuroregeneration Therapy Market

  • 22.1. Russia Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neuroregeneration Therapy Market

  • 23.1. North America Neuroregeneration Therapy Market Overview
  • 23.2. North America Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neuroregeneration Therapy Market

  • 24.1. USA Neuroregeneration Therapy Market Overview
  • 24.2. USA Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neuroregeneration Therapy Market

  • 25.1. Canada Neuroregeneration Therapy Market Overview
  • 25.2. Canada Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neuroregeneration Therapy Market

  • 26.1. South America Neuroregeneration Therapy Market Overview
  • 26.2. South America Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neuroregeneration Therapy Market

  • 27.1. Brazil Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neuroregeneration Therapy Market

  • 28.1. Middle East Neuroregeneration Therapy Market Overview
  • 28.2. Middle East Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neuroregeneration Therapy Market

  • 29.1. Africa Neuroregeneration Therapy Market Overview
  • 29.2. Africa Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neuroregeneration Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Neuroregeneration Therapy Market Competitive Landscape
  • 30.2. Neuroregeneration Therapy Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

31. Neuroregeneration Therapy Market Other Major And Innovative Companies

  • 31.1. Novartis International AG
  • 31.2. Stryker Corporation
  • 31.3. Biogen Inc.
  • 31.4. Synovis Life Technologies Inc.
  • 31.5. Integra LifeSciences Holdings Corporation
  • 31.6. AxoGen Inc.
  • 31.7. Denali Therapeutics Inc.
  • 31.8. Aspen Neuroscience Inc.
  • 31.9. Neurona Therapeutics Inc.
  • 31.10. Lineage Cell Therapeutics Inc.
  • 31.11. Checkpoint Surgical Inc.
  • 31.12. Stemedica Cell Technologies Inc.
  • 31.13. Polyganics B.V.
  • 31.14. Epineuron Technologies Inc.
  • 31.15. NeuExcell Therapeutics Inc.

32. Global Neuroregeneration Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neuroregeneration Therapy Market

34. Recent Developments In The Neuroregeneration Therapy Market

35. Neuroregeneration Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Neuroregeneration Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Neuroregeneration Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Neuroregeneration Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer